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Feline immunodeficiency virus (FIV) multiplication is totally blocked by incubation of infected cells at 41°. This inhibition
does not take place with a thermoresistant strain of FIV, designated m41, indicating the role played by the viral genome in
temperature sensitivity. We have investigated the steps in the life cycle of wild-type FIV that are thermosensitive and found
that they depend on the host cells infected. In CrFK cells, FIV replication was inhibited after the penetration step at 41°.
Synthesis of viral RNA and DNA was barely detectable and no viral antigen appeared in the extracellular medium.
Nevertheless, viral multiplication resumed on incubation at 37°, suggesting a state of latency at the elevated temperature.
In peripheral blood mononuclear cells (PBMCs), the FIV cycle was inhibited at 41° after the synthesis of viral DNA. Several
viral mRNAs failed to appear as fully spliced products and no viral antigen was found in the extracellular medium. As in CrFK
cells, viral multiplication occurred in PBMCs after a shift to the permissive temperature. These results suggest that at least
two steps in the viral life cycle are sensitive to 41° and that two different viral functions of the thermoresistant mutant m41
are modified to overcome temperature sensitivity. © 1999 Academic Press
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Feline immunodeficiency virus (FIV) belongs to the
enus lentivirus of the Retroviridae family (Miyazawa et
l., 1991; Pedersen et al., 1987; Talbott et al., 1989). FIV
nfection in domestic cats causes an acquired immuno-
eficiency syndrome (AIDS) similar to that seen on in-
ection with human immunodeficiency virus type 1
HIV-1) (Ishida and Tomoda, 1990; Pedersen et al., 1989;
amamoto et al., 1988). Because of its genetic and patho-
enic similarities to HIV-1, FIV is an animal model for
uman AIDS research (Bennett and Hart, 1995).
We recently isolated a thermoresistant strain of FIV,
esignated m41, that is able to replicate at 41° on Cran-
ell feline kidney (CrFK) cells (Alix et al., 1998), unlike the
ild-type strain (wt), which is unable to replicate on
hese cells at this elevated temperature.
The purpose of the present study was to identify the
hase(s) in the viral life cycle that the thermoresistant
train was able to surmount at 41° in CrFK cells and
eripheral blood mononuclear cells (PBMCs). We
herefore carefully examined the life cycle of the wt
train at the elevated temperature by following antigen
roduction in the supernatants of infected cells as well
s virus penetration and DNA and RNA synthesis.
urthermore, temperature-shift experiments were con-
1 To whom reprint requests and correspondence should be ad-
1ressed. Fax: 33 (0)3 88 56 63 03. E-mail: ordi@viro-ulp.u-strasbg.fr.
309ucted to pinpoint more precisely the temperature-
ensitive phase.
RESULTS
iral internalization in CrFK cells
Infection of CrFK cells at 41° with wt FIV appears to be
locked at a very early stage of the infectious cycle (see
elow). We therefore investigated whether FIV could
enetrate at the elevated temperature.
Virus was adsorbed onto CrFK cells at 14° for 3 h and
enetration was then allowed to occur by shifting the
ultures to 37° or 41° for 5 or 30 min. Finally, after a
rypsin treatment to remove extracellular virus, cells
ere incubated at 37° for 12 days (Fig. 1) and the culture
edium was assayed at regular intervals for the pres-
nce of the viral matrix protein, the p15 antigen. When
rypsin was added immediately after the adsorption pe-
iod no viral replication was observed, as indicated by
he absence of p15 antigen in the culture supernatants
Fig. 1). We also noted that when FIV-infected CrFK cells
ere allowed a 30-min penetration time at 37° and 41°,
irus release into the culture supernatant was more
apid than when cells were allowed only a 5-min pene-
ration time at these two temperatures. This suggested
hat a 5-min period of penetration is suboptimal and that
rypsin removed virus that had not yet penetrated after
his period. When internalization was carried out for 5
in at 37° or 41°, viral replication at 37° was similar (Fig.
). The same results were observed with a penetration
0042-6822/99 $30.00
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310 ALIX, MARTIN, AND BRAUNWALDime of 30 min at 37° and 41°. These experiments thus
emonstrate that the wt FIV strain could be internalized
n CrFK cells equally well at 41° and 37°.
These data were confirmed by electron micro-
FIG. 1. P15 antigen release at 37°C from CrFK cells infected with wt
r 30 min at 37 or 41°. The cells were then treated with trypsin and inc
etermined by ELISA (optical density at 492 nm): no trypsin, incubatio
negative control) (3); 5 min at 37°/trypsin/37° (F); 5 min at 41°/trypsi
FIG. 2. Ultrathin sections of wt-infected CrFK cells at 41°: (a) wt viru
t virus particles.copy: after 5 min at 41°, we observed FIV adsorbed at
he cell membrane (Fig. 2a) and, within the cells,
hagocytic vesicles containing several viral particles
Fig. 2b).
rus was adsorbed to CrFK cells at 14° for 3 h, then internalized for 5
at 37°. P15 antigen release from the cells in the culture medium was
7°C (1); no trypsin, incubation at 41° (3); 0 min at 37°C/trypsin/37°
n); 30 min at 37°/trypsin/37° (m); 30 min at 41°/trypsin/37° (h).
bed at the cell membrane. (b) Phagocytic vesicles containing severalFIV. Vi
ubated
n at 3s adsor
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311TEMPERATURE SENSITIVITY OF FIV LIFE CYCLEiral replication at 37° and 41° in CrFK cells
Viral RNA could readily be detected by reverse tran-
cription polymerase chain reaction (RT-PCR) in wt-in-
ected CrFK cells incubated at 37° as soon as the first
ew days postinfection (p.i.) and its level steadily in-
reased until about the 15th day p.i. At 41°, only a small
mount of viral RNA was detected throughout the entire
xperiment (Figs. 3a, 3b). Viral DNA was found in in-
ected CrFK cells at 37°, the permissive temperature,
rom 3 days p.i. onward (Fig. 3c). However, at 41°, only
race amounts of viral DNA could be amplified by PCR
Fig. 3d) and this may be explained in part by a poorer
ensitivity of the DNA PCR as compared with the RT-PCR.
oreover, it was not possible to find any p15 antigen in
he culture supernatant in wt-infected CrFK cells at 41°
Fig. 1 and Alix et al., 1998).
To demonstrate that the metabolism of CrFK cells was
ot altered at the high temperature, we examined, in
arallel experiments, the replication of the thermoresis-
FIG. 3. Detection of viral nucleic acids in the wt- and m41-infected
rFK cells at 37° and 41°. The wt-infected CrFK cells were analyzed for
iral RNA by RT-PCR at 37° (a) and 41° (b) and for viral DNA by PCR at
7° (c) and 41° (d). The m41-infected CrFK cells were analyzed for viral
NA at 37° (e) and 41° (f) and for viral DNA at 37° (g) and 41° (h).
amples were taken from Days 1 to 29 postinfection (lanes 1–29). MW,
NA molecular weight marker VI (Boerhinger Mannheim); T2, negative
ontrol (sterile water instead of cDNA or DNA); T92, negative control
uninfected CrFK cells); T1, positive control sample (infectious clone
FIV-14-Petaluma amplified by PCR with primers G3 and G4).ant m41 strain at 41°. As shown in Fig. 3e to 3h, viral bNA and DNA were detected equally well at 37° and 41°
s early as the fourth day postinfection.
hifting infected CrFK cells from 41° to 37°
To determine whether the inhibition of the wt replica-
ion at 41° was reversible, wt-infected CrFK cells were
hifted from 41° to 37°. Whatever the duration of incu-
ation of the wt-infected CrFK cells at 41° (6, 8, and 13
ays), as soon as they were shifted to 37° the amount of
15 antigen in the culture supernatant increased so as to
each a level similar to that found in the supernatant of
ells continuously grown at 37° (Fig. 4A). A period of
bout 7 days after the shift to 37° was necessary for p15
ntigen to be detected. This may be explained by the 4-
o 7-day period required for the synthesis of viral DNA
Fig. 4B, a) and RNA (Fig. 4B, b) at 37°, which is similar
o that of a virus incubated at 37° right from the begin-
ing of infection (Fig. 3).
hifting infected CrFK cells from 37° to 41°
We wished to determine whether wt replication could
ccur at 41° if the early steps of infection, such as DNA
ynthesis, were first allowed to take place at 37°. Shifting
he wt-infected CrFK cells from 37° to 41° after 4 and 8
ays p.i. was followed by a constant level of p15 antigen
elease into the culture supernatant (Fig. 5A). In parallel,
he pattern of transcription of FIV in wt-infected CrFK
ells was analyzed using RT-PCR and the primer pairs
1/A2, S1/A3, and S4/A5. Figure 5B shows the singly
pliced mRNA for the envelope protein detected by RT-
CR. During the initial period of incubation at 37°, the
mount of mRNA increased (Fig. 5B, a and b). Stable
mounts of singly spliced mRNA were found after trans-
er to the elevated temperature (Fig. 5B, a and b). Similar
esults were obtained with the other two groups of
pliced mRNA and viral DNA (data not shown). Since the
xperiments in Fig. 5A and 5B were carried out with the
ulture medium being removed at 4-day intervals and
eplaced by fresh medium, the cells that had been in-
ected at 37° produced relatively large amounts of virus
nd mRNA during the 4-day period at 41°. The absence
f an overall increase in p15 antigen or singly spliced
RNA, such as occurs at 37°, could be explained by the
ailure of the virus produced at 41° to initiate new infec-
ious cycles in the surrounding cells.
iral replication at 37° and 41° in PBMCs
Viral DNA could be detected in wt- and m41-infected
BMCs at both temperatures (Fig. 6B), indicating that wt
NA was present in PBMCs at 41° (Fig. 6B, b) in contrast
o the results obtained using CrFK cells. However, as in
he CrFK cell line, the wt strain was not able to replicate
n PBMCs at the nonpermissive temperature, as shown
y the absence of p15 antigen in the culture superna-
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312 ALIX, MARTIN, AND BRAUNWALDants (Fig. 6A). Furthermore, singly spliced mRNA was
ot detected by RT-PCR and Southern blotting in the
t-infected PBMCs at 41° (Fig. 6C, b), whereas the other
wo groups of mRNA (unspliced and multiply spliced)
ere detected (data not shown). The same experiments,
erformed with the m41 strain, showed that synthesis of
iral RNA (Figs. 6C, c; 6C, d) and DNA (Figs. 6B, c; 6B, d)
nd the production of p15 antigen (Fig. 6A) occurred at
1°, indicating that the metabolism of PBMCs at the high
emperature was not a limiting factor.
hifting infected PBMCs from 41° to 37° or from 37°
o 41°
To investigate whether the inhibition in wt replication
t 41° was reversible, wt-infected PBMCs were incu-
ated at 37° after 4, 7, and 11 days at 41°. Results similar
o those described for the CrFK cells were obtained (Fig.
). As long as the wt-infected PBMCs were incubated at
he high temperature, no p15 antigen could be detected
n the culture supernatant (Fig. 7). However, as soon as
FIG. 4. (A) P15 antigen release from CrFK cells infected with the wt
edium was determined by ELISA (optical density at 492 nm): wt at 3
1° for 13 days (}). (B) Viral RNA (a) and DNA (b) in wt-infected CrFK ce
sed to detect RNA and DNA, respectively. The lanes represent sampt-infected PBMCs were shifted to the permissive tem- rerature, the amount of p15 antigen increased, reaching
level similar to that of PBMCs incubated at 37°.
Reciprocal experiments showed that once the wt-in-
ected PBMCs were shifted from 37° to 41°, the amount
f p15 antigen in the culture supernatant decreased with
ime (Fig. 8). This indicated that the late steps in the
nfectious cycle, occurring after DNA synthesis, were not
unctional at the high temperature.
DISCUSSION
Experiments were first performed in CrFK cells be-
ause they allowed multiplication of the m41 strain at 41°
ut not the wt strain (Alix et al., 1998). The effect of an
levated temperature on virus replication was then in-
estigated using freshly prepared PBMCs since infection
f primary cells is more likely to reflect the events that
ccur in vivo. The results demonstrate that FIV multipli-
ation at 41° is inhibited at different periods of the virus
ycle in CrFK cells and PBMCs. In CrFK cells, infection
as stopped at a point between virus penetration and
at 37° after 6, 8, or 13 days at 41°. P15 antigen release in the culture
wt at 41° (h), wt at 41° for 6 days (F), wt at 41° for 8 days (), wt at
r 6 and 8 days at 41° followed by a shift to 37°. RT-PCR and PCR were
Days 2 to 16 at 37°. T92, negative control (noninfected CrFK cells).strain
7° (n),
lls afteeverse transcription, whereas in PBMCs the inhibition in
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313TEMPERATURE SENSITIVITY OF FIV LIFE CYCLEiral multiplication at 41° appeared to be due to a defect
n the splicing of mRNA. Some viral DNA could never-
heless be detected in CrFK cells at 41° after 4 weeks of
nfection and this could be accounted for in several
ays: (i) thermoresistant viruses could be selected; (ii)
iral replication may not have been completely inhibited
t 41° but simply slowed down; (iii) reverse transcription
ay take place to a limited extent within extracellular
IV-1 virions (Zhang et al., 1993; Lori et al., 1992; Trono,
992). Infection of PBMCs with the wt and m41 strains at
7° and 41° gave results similar, with respect to virus
roduction, to those observed in CrFK cells. The m41
train replicated just as well at 41° as at 37°, indicating
hat PBMCs were not affected by the elevated tempera-
ure. Surprisingly enough, viral DNA could be detected in
t-infected PBMCs at 41°. The first steps leading to the
ynthesis of cDNA could thus be accomplished at the
igh temperature in PBMCs. Experiments to detect
pliced viral mRNA demonstrated that viral transcripts
ere not fully processed in wt-infected PBMCs at 41°,
iven that one of the three groups of mRNA, the singly
FIG. 5. (A) P15 antigen release from wt-infected CrFK cells cultured a
m): wt at 37° (n), wt at 41° (h), wt at 37° for 4 days (F), wt at 37° for 8 d
rFK cells, was amplified by RT-PCR and visualized by gel electropho
amples from Days 0 to 32 postinfection. MW, DNA molecular weightpliced mRNA, was lacking in these cells; in m41- wnfected PBMCs incubated at 41°, these singly spliced
RNAs could be found. The fact that singly spliced
RNAs were absent at 41° could be explained in differ-
nt ways: at 41° (i) the splicing sites were not recognized
y the specific enzymes; (ii) the RRE sites were not
ecognized by the Rev protein; (iii) the multiply spliced
RNA encoding Rev and/or the corresponding protein
as unstable.
Temperature-shift experiments with wt-infected CrFK
ells or wt-infected PBMCs from 41° to 37° demon-
trated that, as long as the infected cells were incubated
t 41°, viral replication was inhibited. However, as soon
s the infected cells were incubated at 37°, viral repli-
ation resumed, just as efficiently as for a virus incu-
ated at 37° from the beginning, suggesting that the
nhibition was reversible. It may be speculated that the
t virus was present in the RNA form and maintained
ithout any major damage in the cytoplasm of the in-
ected CrFK cells at 41°. Alternatively, the small amount
f viral DNA observed in CrFK cells at 41° could account
or the ability of the virus to resist at 41° and multiply
ter 4 or 8 days at 37° was determined by ELISA (optical density at 492
. (B) The singly spliced viral RNA for the envelope protein, in wt-infected
t at 37° for 4 days (a), wt at 37° for 8 days (b). The lanes represent
rhinger-Mannheim).t 41° af
ays ()
resis: when the cells were shifted to 37°. On the other hand, in
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314 ALIX, MARTIN, AND BRAUNWALDBMCs, our results clearly demonstrate that FIV may
stablish a state of latency at 41°, in a proviral DNA form.
Experiments in which the wt-infected CrFK cells were
hifted from 37° to 41° showed that the proviral state
ormed at 37° could still be expressed at the high tem-
erature and could produce new virions. The infectivity of
he virus material that accumulated at 41° was further
onfirmed by assaying at 37° (data not shown). The
onstant level of viral replication after transfer to the high
emperature could therefore be explained by the fact that
he new virions could not productively infect the adjoin-
ng uninfected cells at 41°. This would also bear out an
FIG. 6. (A) P15 antigen release from PBMCs infected with the wt and
m): wt at 37° (n), wt at 41° (h), m41 at 37° (F), m41 at 41° (m). (B) Th
ag-specific primers—wt at 37° (a), wt at 41° (b) (note that the 25-day
or viral RNA by RT-PCR using S1/A3 primers, at 37° and at 41°. (C) Sin
y Southern blotting as described under Materials and Methods: wt at 37
rom Days 4, 8, 11, 18, 22, and 25 postinfection. MW, DNA molecular we
FIV-14-Petaluma amplified by PCR with primers G3 and G4).arly inhibition of the viral cycle, after the internalization pf the virus but before the synthesis of viral DNA in the
t-infected cells at 41°, and indicates that the late steps
ay occur at the elevated temperature. When cyclohex-
mide, an inhibitor of mRNA translation, was added to the
ulture medium for 2 days during the 41° incubation
eriod, the level of virus decreased (data not shown),
onfirming that the constant level of p15 antigen de-
ected in the culture supernatant at 41° was correlated
ith virus production. It is interesting to note that, in
ontrast to CrFK cells, shifting of wt-infected PBMCs
rom 37° to 41° resulted in a decrease in virus particle
roduction in the culture supernatant. This can be ex-
trains at 37° and 41° was determined by ELISA (optical density at 492
nd m41-infected PBMC were analyzed for viral DNA by PCR using FIV
was lost during the experiment), m41 at 37° (c), m41 at 41° (d)—and
iced viral RNAs from PBMCs incubated at 37° and 41° were analyzed
t at 41° (b), m41 at 37° (c), m41 at 41° (d). The lanes represent samples
(Boerhinger-Mannheim); T1, positive control sample (infectious clonem41 s
e wt- a
sample
gly spl
° (a), w
ight VIlained by the finding that, in PBMCs, a late step in viral
r
t
m
m
t
t
o
m
w
m
s
c
b
d
T
m
e
P
s
s
t
G
a (), w
a
315TEMPERATURE SENSITIVITY OF FIV LIFE CYCLEeplication is temperature sensitive. Accordingly, al-
hough there is an accumulation of correctly spliced
RNA in PBMCs at 37°, continuous production of mature
RNA would cease after the shift at 41°.
Taken together, these results demonstrate that inhibi-
ion of virus replication occurs at 41°, whatever the cell
ype, albeit at different steps from one cell type to an-
ther. This work was undertaken to learn which step(s)
ay be surmounted by m41 at 41° that is(are) blocked in
t-infected cells. It can thus be deduced that, at 41°, the
41 strain, in contrast to the wt strain, was able to
ynthesize DNA in CrFK cells and to transcribe and
FIG. 7. P15 antigen release from wt-infected PBMCs at 37° after 4, 8
t 37° (n), wt at 41° (h), wt at 41° for 4 days (F), wt at 41° for 8 days
FIG. 8. P15 antigen release from PBMCs infected with the wt strain
t 492 nm): wt at 37° (n), wt at 41° (h), wt at 37° for 4 days (F), wt at 37° foorrectly splice mRNA in PBMCs. Therefore, it is possi-
le that mutations affecting two different proteins or two
ifferent regions of an FIV protein occur in the m41 strain.
he construction of chimeric viruses between wt and
41 has been undertaken to investigate this further.
Our results demonstrate that 41° is a temperature high
nough to inhibit viral replication in CrFK cells and
BMCs in vitro while enabling the selection of thermore-
istant strains (Alix et al., 1998). Various reports have
uggested that elevation of temperature is a potential
herapeutic modality in patients with AIDS (Owens and
asper, 1995; Steinhart et al., 1996; Weatherburn, 1988;
days at 41° was determined by ELISA (optical density at 492 nm): wt
t at 41° for 11 days (}).
after 4, 8, or 11 days at 37° was determined by ELISA (optical density, or 11at 41°
r 8 days (), wt at 37° for 11 days (}).
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316 ALIX, MARTIN, AND BRAUNWALDatvin, 1988; Yatvin et al., 1993). However, it should not be
orgotten that thermoresistant strains could readily ap-
ear after several successive treatments during hyper-
hermic therapy in AIDS patients. Indeed, such thermore-
istant strains able to replicate at an elevated tempera-
ure would be unscathed by fever and hyperthermic
herapy would then be useless in vivo. Furthermore, such
strain could have an increased virulence as compared
ith its wt counterpart, as has already been described
or other viruses (Kirn and Keller, 1983). Finally, in the
ase of FIV, high-temperature passage for 1 or 2 weeks
oes not adversely affect the ability of the virus to survive
nd then efficiently replicate when shifted to a permis-
ive temperature.
MATERIALS AND METHODS
irus production
The wild-type Villefranche strain and the m41 strain
erived from it were propagated on IRC4 cells, as al-
eady described (Alix et al., 1998). To prepare viral
tocks, culture supernatants were collected, centrifuged,
nd stored at 280° until use. The viral concentration in
ell-free supernatants was estimated by enzyme-linked
mmunosorbent assay (ELISA) of p15 antigen release
Alix et al., 1998), reverse transcriptase activity (Martin et
l., 1995), and the measurement of tissue culture infec-
ious dose 50 (TCID50) (Reed and Muench, 1938). For the
lectron microscopy experiments, the supernatant in-
olved was used at a 10-fold concentration by filtration
n an ultrafiltration cell (Amicon, USA) with a XM 300
embrane (Diaflo Ultrafilters, Ireland) under a pressure
f 3 atms.
ell culture and infection
CrFK cells (Crandell et al., 1973), a permissive cell line
or FIV provided by G. Pancino (Institut Cochin, Paris,
rance), were maintained in Dulbecco’s modified Eagle’s
edium (DMEM, Biochrom KG, Germany) containing 1%
lutamax (Gibco-BRL, England), 10% fetal calf serum
FCS, Sigma, USA), and antibiotics, 1‰ fungizone (Gibco-
RL) and were incubated in a humidified incubator under
% CO2 at 37°. For the experiments, CrFK cells (1.5 3 10
5)
ere seeded in four-well culture plates (Falcon, Becton
ickinson, USA) and incubated at 37° under 5% CO2 for
4 h. At this time, cells were confluent and there was no
urther multiplication (contact inhibition). After being
ashed with phosphate-buffered saline (PBS), the cell
onolayers were infected with 200 ml of wt or m41
trains containing 200 TCID50 for 3 h at 37° or 41°. The
noculum was then discarded and the monolayers, after
wo washes, were recovered with DMEM supplemented
ith 5% FCS and 1‰ fungizone; the culture plates were
hen incubated at 37° or 41° in a humidified incubator Eontaining 5% CO2. The culture medium was removed
wice a week and frozen at 280° for determination of p15
ntigen by ELISA. The cells, recovered by scraping, were
sed to detect the presence of viral DNA and RNA by
CR and RT-PCR, respectively (see below).
PBMC isolation has already been described (Martin et
l., 1995). For infection, PBMC pellets were infected with
t and m41 (1000 TCID50 per 1 3 10
6 cells) and incu-
ated at 37° and 41°. Three hours later, cell pellets were
ashed in RPMI 1640 medium (Gibco-BRL), and after
entrifugation, the cells were resuspended in RPMI 1640
edium supplemented with 10% heat-inactivated FCS,
0 U/ml human recombinant interleukin-2 (Boehringer-
annheim, Germany), 1% caryoser (Biosepra, France),
nd 1‰ fungizone. One million cells were then seeded in
our-well culture plates (Falcon) in a volume of 750 ml and
ncubated at 37° or 41°. Twice a week cell samples were
entrifuged at 3000 rpm/min (centrifuge Biofuge 13, He-
eaus) for 10 min. The presence of p15 antigen in the
upernatant was determined by ELISA and the presence
f viral DNA and RNA in the cell pellet was detected by
CR and RT-PCR, respectively. For the maintenance of
ell cultures, half of the medium was removed twice a
eek and replaced by fresh medium.
irus entry assay
i. Trypsin treatment. CrFK (1.5 3 105) cells were in-
ected with a volume of 200 ml of 200 TCID50 of the wt
train. After 3 h incubation at 14° for viral adsorption,
ells were washed three times with cold PBS to remove
nbound virus and then incubated in water baths at 37°
r 41° for 5 or 30 min to allow viral internalization.
oninternalized viruses were removed by trypsin treat-
ent (bovine pancreas trypsin, type I, Sigma, USA) at a
inal concentration of 2 mg/ml for 10 min at 37°. The
rypsin was then blocked by washes with 1 mM phenyl-
ethylsulfonyl fluoride (Sigma, USA), 20 U/ml aprotinin
Sigma, USA), and 3% bovine serum albumin (fraction V,
uromedex, France). The cells were washed three times
nd DMEM supplemented with 5% FCS was then added
o the culture plates which were incubated at 37°. Sam-
les of the culture medium were removed twice a week
or 1 month and frozen at 280° until use to determine the
15 antigen by ELISA.
ii. Electron microscopy. Control and wt-infected CrFK
ells at 41° and 37° were fixed for 30 min with cacody-
ate-buffered 2.5% glutaraldehyde, washed with cacody-
ate, and postfixed with 1% osmium tetroxide for 60 min
t 14°. The cells were dehydrated in ethanol and em-
edded in Epon. Ultrathin sections, stained with uranyl
cetate and lead citrate, were examined under a Philips
M 410 electron microscope.
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317TEMPERATURE SENSITIVITY OF FIV LIFE CYCLEligonucleotide primers
Seven amplification primers were used in this study.
heir sequence and exact position, derived from the
equence of FIV Petaluma strain (FIV-14) (Talbott et al.,
989), were as follows: G3 (sense primer): 59-GCACAC-
TCCCCCT GATGCTCC-39 [nucleotides (nt) 1272–1294];
4 (antisense primer): 59-TCCCGAATTCT TTCTATTTCCT-
GCAACA-39 (nt 1880–1851); S1 (sense primer): 59-GTG-
AGC GGACTCGAGCTCA-39 (nt 491–510); A2 (antisense
rimer): GTCTCTGGTATATCAC CAGG-39 (nt 794–775); A3
antisense primer): CCGGAGGTAGCCTAGATATG (nt 5332–
313); S4 (sense primer): GAGTGAAGAAGGACCACTAA
nt 6352–6371); A5 (antisense primer): AGCTTCCTGAA-
CGATCTTC (nt 9040–9021). G3/G4, a gag-based primer
air, was designed to amplify a 608-bp product to detect
iral RNA and DNA. Amplification primers S1, A2, A3, S4,
nd A5 were used for FIV-specific transcripts (unspliced,
ultiply spliced, and singly spliced mRNA) (Ikeda et al.,
996). The splice sites in the FIV m41 genome were
redicted from the transcription pattern of several FIV
RNA which have been reported previously (Phillips et
l., 1992; Tomonoga et al., 1992, 1993). Ikeda et al. (1996)
howed that the location of these primers allowed non-
pliced, singly spliced, and multiply spliced mRNA to be
etected.
CR assays
i. Viral RNA. Total cellular RNA was extracted from
.5 3 105 wt or m41-infected CrFK cells and from 2 3 106
t or m41-infected PBMCs at 37° and 41°, using the
Neasy Mini kit (Qiagen) according to the manufacturer’s
rocedure. RNA samples were digested with 2.5 U of
Nase I (DNase I RNase-free, Boehringer-Mannheim,
ermany) for 15 min at 37°. The DNase was inactivated
y heating the samples for 10 min at 95°. RNA samples
3 mg) were then mixed with 300 ng of oligo(dT)15 primer
Boehringer-Mannheim, Germany), heated at 68° for 10
in, and cooled on ice. First-strand cDNA synthesis was
arried out at 37° for 1 h in a total volume of 20 ml
ontaining 50 mM Tris–HCl (pH 8.3), 75 mM KCl, 3 mM
gCl2, 10 mM dithiothreitol, 4 mM deoxynucleoside
riphosphates, and 100 U of Moloney murine leukemia
irus reverse transcriptase (Gibco-BRL). Each cDNA mix-
ure (6 ml) was subsequently amplified in a total volume
f 100 ml containing 20 mM Tris–HCl (pH 8.55 at 25°), 16
M (NH4)2SO4, 3.5 mM MgCl2, 250 mM deoxynucleotide
riphosphates, 2.5 U of Taq polymerase (Gibco-BRL), and
0 pmol of each primer. The PCR mixture was overlaid
ith three drops of mineral oil (Sigma) and incubated at
4°, 55°, and 72° for 1, 2, and 2 min, respectively. This
ycle was repeated 30 times in a Perkin–Elmer Cetus
NA Thermal Cycler PJ2000.
ii. Viral DNA. Total DNA was extracted from 3 3 105rFK cells and 1 3 106 PBMCs infected with wt and m41,sing the QIAamp Blood Kit (Qiagen). Ten microliters of
ach DNA sample was subsequently amplified, as de-
cribed above.
nalysis of PCR products
To detect PCR products amplified with the primer pair
3/G4, DNA was analyzed on a 1% horizontal agarose
el. DNA was visualized by UV fluorescence after stain-
ng with ethidium bromide. PCR products amplified with
rimer pairs S4/A5, S1/A3, and S1/A2 were analyzed on
2% horizontal agarose gel. To denature DNA before
lotting, gels were soaked in 0.5 M NaOH and 1.5 M
aCl for 10 min, washed twice with water, and neutral-
zed with 1 M Tris–HCl, pH 8.0, and 1.5 M NaCl for 10 min.
he DNA was transferred to a nylon membrane (Hybond
1, Amersham) by blotting 16 h in 203 SSC (3 M NaCl,
.3 M Na citrate, pH 7.0). Hybridizations were performed
vernight with digoxygenin-labeled probes (DIG High
rime, Boehringer-Mannheim, Germany). The locations
f the hybridization probes were (A) nt 1–5421 and (B) nt
210–9474. Probes A were used to detect PCR products
mplified with primer pairs S1/A3 and S1/A2, and probe
to detect PCR products amplified with the primer pair
4/A5.
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